| Product NDC: | 58118-2788 |
| Proprietary Name: | tizanidine hydrochloride |
| Non Proprietary Name: | tizanidine hydrochloride |
| Active Ingredient(s): | 2 mg/1 & nbsp; tizanidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58118-2788 |
| Labeler Name: | Clinical Solutions Wholesale |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021447 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120206 |
| Package NDC: | 58118-2788-0 |
| Package Description: | 1 CAPSULE, GELATIN COATED in 1 PACKET (58118-2788-0) |
| NDC Code | 58118-2788-0 |
| Proprietary Name | tizanidine hydrochloride |
| Package Description | 1 CAPSULE, GELATIN COATED in 1 PACKET (58118-2788-0) |
| Product NDC | 58118-2788 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tizanidine hydrochloride |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120206 |
| Marketing Category Name | NDA |
| Labeler Name | Clinical Solutions Wholesale |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |